Metformin is one of the most widely prescribed medications in the world, and for good reason: it lowers blood sugar effectively, is inexpensive, and has a long safety track record. But it also comes with real downsides, particularly gut-related side effects and the potential for nutritional deficiencies over time. Here’s a closer look at both sides.
Blood Sugar Control
Metformin’s primary job is lowering blood sugar, and it does this well. In clinical trials, people taking metformin as their only diabetes medication saw their HbA1c drop by an average of 1.12 percentage points compared to placebo. That’s a meaningful reduction, often enough to bring someone from poorly controlled diabetes into a much safer range.
The drug works mainly by dialing down the liver’s production of glucose. Your liver constantly releases sugar into the bloodstream, and in type 2 diabetes, it overproduces. Metformin puts the brakes on that process. This is why it’s particularly effective at lowering fasting blood sugar levels, the numbers you see first thing in the morning before eating.
Weight: Neutral to Mildly Helpful
Unlike many diabetes medications that cause weight gain, metformin tends to produce modest weight loss or at least keep weight stable. Across multiple studies, weight loss typically ranges from about 2 to 4 kilograms (roughly 4 to 9 pounds) over several months to a few years. In the large Diabetes Prevention Program trial, participants on metformin lost an average of 2.1 kilograms. Those who stuck closely to their medication schedule lost more, averaging a 3.5% reduction in body weight.
The effect appears to be partly appetite-related. Research shows metformin has a dose-dependent effect on how much food people consume at meals. Some studies in people with diabetes have reported weight loss as high as 8 kilograms over 24 weeks, though results vary widely depending on the person, the dose, and whether dietary changes are happening at the same time. Metformin is not a weight loss drug, but the fact that it doesn’t add pounds is a genuine advantage over alternatives like insulin or certain other oral medications.
Digestive Side Effects
This is metformin’s biggest drawback. Up to 20% of people experience some form of gastrointestinal trouble, and for a significant minority, the symptoms are bad enough to stop taking it. The most common complaints, based on a large meta-analysis of clinical trials:
- Diarrhea: affects about 13% of users
- Bloating: about 9%
- Abdominal pain: about 7%
- Nausea: about 6%
- Vomiting: about 4%
- Constipation: about 2%
These side effects are worst in the first few weeks and often improve as your body adjusts. This is why doctors typically start at a low dose (500 mg once or twice daily) and increase by 500 mg each week, giving your system time to adapt. Taking metformin with food also helps considerably.
Extended-Release May Be Easier on the Gut
If digestive symptoms are a problem, the extended-release version of metformin is worth asking about. In a prospective study of newly diagnosed patients, 45% of people on the standard immediate-release form reported gut side effects at six months, compared to just 25% on extended-release. The extended-release group had virtually no diarrhea at the six-month mark, while bloating was cut roughly in half. Both formulations control blood sugar similarly, so the switch is purely about tolerability.
Vitamin B12 Depletion
Long-term metformin use can lower vitamin B12 levels, and this risk is often overlooked. Updated product information now classifies B12 deficiency as a common side effect, potentially affecting up to 1 in 10 people taking the drug. Low B12 can cause fatigue, nerve tingling or numbness, and a specific type of anemia. The tricky part is that these symptoms can look a lot like diabetic nerve damage, so the true cause can be missed.
If you’ve been on metformin for several years, periodic B12 monitoring is reasonable, especially if you notice new numbness in your hands or feet or unexplained fatigue. The fix is straightforward: B12 supplements are cheap and effective.
Lactic Acidosis: Overstated but Real
For decades, the fear of lactic acidosis (a dangerous buildup of acid in the blood) kept many doctors cautious about prescribing metformin, particularly for people with kidney problems. In practice, this risk is very low for people with normal or mildly reduced kidney function. The concern becomes real only when kidneys are significantly impaired, because the body can’t clear the drug efficiently.
The FDA now sets clear boundaries: metformin should not be used when kidney filtration drops below 30 mL/min, and starting it is not recommended below 45 mL/min. At those low filtration levels, the rate of acidosis events climbs to about 24 per 1,000 people per year, compared to roughly 4 per 1,000 at near-normal kidney function. For the vast majority of people prescribed metformin, kidney function is checked periodically and this risk remains extremely small.
Cardiovascular Protection: Less Clear Than Expected
Older studies suggested metformin might protect the heart, and this idea has been widely repeated. However, a large 21-year follow-up study published in Circulation found no reduction in major cardiovascular events (heart attacks, strokes, or cardiovascular death) among people taking metformin compared to placebo. The hazard ratio was essentially 1.0, meaning no measurable benefit. This doesn’t mean metformin is harmful for the heart. It simply means the cardiovascular protection that was once assumed may not be as strong as previously thought, at least in people who don’t yet have diabetes.
Benefits Beyond Blood Sugar
Metformin is used for several conditions beyond type 2 diabetes, most notably polycystic ovary syndrome (PCOS). In women with PCOS, metformin reduces circulating androgen levels, improves insulin sensitivity, and helps restore regular menstrual cycles. Multiple studies have shown it can trigger ovulation, either on its own or combined with other fertility medications. For women with PCOS who are struggling with irregular periods or trying to conceive, metformin addresses the underlying insulin resistance that drives many of the syndrome’s symptoms.
There is also growing interest in metformin’s potential effects on aging and cancer prevention. Observational studies have linked metformin use with lower cancer incidence and mortality, though no randomized trial has confirmed a cancer prevention effect yet. The TAME trial (Targeting Aging with Metformin) is designed to test whether metformin can delay the onset of age-related diseases as a group, including cardiovascular disease, cancer, and dementia, in 3,000 older adults across the United States. These are intriguing possibilities, but they remain unproven.
Practical Considerations
Metformin is generic and costs very little, often just a few dollars per month. It’s been in use since the 1950s in Europe and since 1995 in the United States, which means its safety profile is better understood than almost any other diabetes drug. It doesn’t cause low blood sugar on its own, which is a significant safety advantage over medications like insulin or sulfonylureas. You can exercise, skip a meal, or adjust your routine without the constant worry of a dangerous blood sugar crash.
The adjustment period is the hardest part for most people. The first few weeks of gradually increasing the dose can involve enough stomach trouble to be discouraging. But for those who push through or switch to extended-release, metformin often becomes a medication that fades into the background of daily life, doing its job quietly with minimal ongoing side effects.